Drug Company To Pay Consumers And State For Precluding Competition

Anticompetitive Conduct Delayed Generic Competition, Causing Consumers And The State To Pay More For Provigil A settlement between Delaware, 47 other states, the District of Columbia and the drug company Cephalon could result in up to $250,000 to be paid to Delaware consumers to resolve claims the company delayed generic versions of Provigil from entering […]
Source